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Abstract— Changes of serum and extracellular ion concen-
trations occur regularly in patients with chronic kidney disease
(CKD). Recently, hypocalcemia, i.e. a decrease of the extra-
cellular calcium concentration [Ca2+]o, has been suggested
as potential pathomechanism contributing to the unexplained
high rate of sudden cardiac death (SCD) in CKD patients.
In particular, there is a hypothesis that hypocalcaemia could
slow down natural pacemaking in the human sinus node to
fatal degrees. Here, we address the question whether there
are inter-species differences in the response of cellular sinus
node pacemaking to changes of [Ca2+]o. Towards this end,
we employ computational models of mouse, rabbit and human
sinus node cells. The Fabbri et al. human model was updated
to consider changes of intracellular ion concentrations. We
identified crucial inter-species differences in the response of
cellular pacemaking in the sinus node to changes of [Ca2+]o
with little changes of cycle length in mouse and rabbit models
(<83 ms) in contrast to a pronounced bradycardic effect in
the human model (up to >1000 ms). Our results suggest that
experiments with human sinus node cells are required to
investigate the potential mechanism of hypocalcaemia-induced
bradycardic SCD in CKD patients and small animal models
are not well suited.
I. INTRODUCTION
The extracellular milieu in mammals is tightly controlled,
i.e. amongst others the concentration of the essential elec-
trophysiological ions is kept almost constant under physi-
ological conditions. In disease conditions such as chronic
kidney disease (CKD), the body can fail to regulate the
ion concentrations including [K+]o and [Ca2+]o. Patients
suffering from CKD have an exceptionally high risk of
sudden cardiac death (SCD). Indeed, it is 14x higher than
in cardiovascular patients with normal kidney function [1].
This high rate in CKD patients cannot be explained by
traditional SCD risk factors and recent clinical studies using
implantable loop recorders point towards severe bradycardia
and asystole as the prevailing arrhythmias causing SCD in
CKD patients [2], [3]. An initial computational study from
our group suggests a slowing of the cellular pacemaking
rate in the human sinus node caused by reduced [Ca2+]o
We gratefully acknowledge financial support by the Deutsche Forschungs-
gemeinschaft (DFG) through CRC 1173. and by the National Research
Development and Innovation Office (NKFIH PD-125402 and FK-129117).
1A. L. Y. L., and C. S. are with the Institute of Biomedical Engineer-
ing, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
publications@ibt.kit.edu. 2N. N. and A. V. are with the
Department of Pharmacology and Pharmacotherapy, University of Szeged,
Szeged, Hungary. 3A. F. is with the Department of Medical Physiology,
University Medical Center Utrecht, Utrecht, The Netherlands. 4S. S. is
with the Department of Electrical, Electronic and Information Engineering
”Guglielmo Marconi”, University of Bologna, Cesena, Italy.
as a likely mechanism causing bradycardic SCD in CKD
patients [4]. In vitro confirmation of this in silico finding
is required. However, it is not clear which experimental
setting (i.e. human vs. animal sinus node cells) is suit-
able considering the marked difference in pacemaking rate
(mouse: 500bpm, rabbit: 300bpm, dog: 100bpm; human:
60bpm). Therefore, we study inter-species differences of
sinus node cellular pacemaking response to [Ca2+]o changes
using computational models of rabbit, mouse, and human
sinus node cells together with rabbit experimental data.
II. METHODS
A. Model Extension
The original Fabbri et al. model [5] considers constant
intracellular K+ and Na+ concentrations, which is a valid
assumption during cyclic steady-state simulations at the
reference extracellular concentrations. However, the intra-
cellular concentrations are likely to respond to changes of
the extracellular concentrations. Therefore, we extended the
model to account for the dynamic intracellular K+ and Na+
balance based on the influx and efflux of ions carrying the
transmembrane currents. Moreover, we included a current
through the small conductance calcium-activated potassium
channel (ISK) as proposed before [6], [7]. Lastly, we consid-
ered the dependance of the maximal IKr conductance gKr
on [K+]o as described before for other cardiomyocytes [8]:




·(Vm − EK)·(0.9paF + 0.1paS)·piy
(1)
After introducing the changes to the model equations, the
parameters in the upper part of Table I were optimized
with respect to a cost function considering the experimental
values in Table II and the existence of a cyclic steady-
state similar to the method used for the original Fabbri
et al. model detailed in [5]. Table I lists the optimized
parameter values, Table III gives the initial values. The
updated model was validated against experimental action
potential (AP) and calcium transient (CaT) recordings as well
as the effect of mutations similarly to the validation of the
original model [5].
B. Inter-Species Comparison
To compare the effect of [Ca2+]o changes on sinus node
cellular pacemaking between species, we used the Garny et
al. [9] and Severi et al. [10] rabbit models as well as the
Kharche et al. mouse model [11] besides the original and
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TABLE I
SUGGESTED PARAMTER CHANGES FOR THE FABBRI ET AL. HUMAN
SINUS NODE CELL MODEL [5].
Parameter Original model Updated model Change
i NaK max (nA) 8.11e-02 1.37e-01 +68.9%
P CaL (nA/mM) 4.58e-01 5.05e-01 +10.3%
k dl (mV) 4.34 5.85 +34.8%
V dl (mV) -16.45 -7.77 -52.8%
k fl (mV) 5.30 5.17 -2.5%
V fl (mV) -37.40 -12.18 -67.4%
g Kur (µS) 1.54e-04 7.06e-05 -54.2%
g to (µS) 3.50e-03 1.67e-03 -52.3%
g Kr (µS) 4.24e-03 4.99e-03 +17.7%
g Ks (µS) 6.50e-04 8.64e-04 +32.9%
g fK (µS) 2.68e-03 1.17e-02 +337%
g fNa (µS) 1.59-03 6.96e-03 +337%
EC50 SK (mM) - 7.00e-04 new
n SK - 2.2 new
g SK (µS) - 1.65e-04 new
The small conductance calcium-activated potassium (SK) channel was
newly introduced. Moreover, the model was extended by considering gKr
dependance on [K+]o and dynamic changes of [Na+]i and [K+]i.
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Fig. 1. Comparison of clinically observed and simulated effects of HCN4
(If ), SCN5A (INa), and KCNQ1 (IKs) mutations. Details regarding the
clinical data and implementation of the mutations in the human sinus node
cell model were presented with the original model [5]. No clinical data from
non-carrier family members were available for the Y481H, R524Q, D553N
If mutations and E1784K INa mutations. Standard deviation of clinical
data are indicated where available. Clinical data from [5].
updated human models described above. In all of the models,
[Ca2+]o was varied between 0.9 and 2.9 mM. The coupled
systems of ordinary differential equations were numerically
integrated for 100 s to reach a cyclic steady-state.
As wetlab data on this phenomenon are very sparse, we
performed experiments in isolated sinus node tissue from
young New-Zealand white rabbits at 37◦C to complement
our computational analyses. The protocol was approved by
the Review Board of the Department of Animal Health
and Food Control of the Ministry of Agriculture and Rural
Development, Hungary (XIII./1211/2012). The details of the
conventional microelectrode technique were described be-
fore [12]. The calcium content of the bath solution was varied
(0.9 / 1.35 / 1.8 mM) and the cycle length of spontaneous
beating rate was determined from AP recordings in n=6
rabbits.
TABLE II
COMPARISON OF ACTION POTIENTAL (AP) AND CALCIUM TRANSIENT
(CAT) FEATURES.
Marker Experimental Original Updated
[13] model [5] model
MDP (mV) -61.7 ± 4.3 -58.9 -60.9
cycle length (ms) 828 ± 15 815 828
(dV/dt)max (V/s) 4.6 ± 1.2 7.3 6.5
APD20 (ms) 64.9 ± 16.9 86 73.8
APD50 (ms) 101.5 ± 27.0 124 108.2
APD90 (ms) 143.5 ± 34.9 149.3 130.4
AP overshoot (mV) 16.4 ± 0.7 26.4 26.8
DDR100 (mV/s) 48.9 ± 18 48.1 75.7
[Ca]i,min (nM) 105 84 111
[Ca]i,max (nM) 220 189 263
CaT amplitude (nM) 115 105 152
CaTD20 (ms) 138.9 136 117
CaTD50 (ms) 217.4 206 165
CaTD90 (ms) 394.0 552 478
Abbreviations: maximum diastolic potential (MDP); AP duration (APD),
diastolic depolarization rate over the first 100 ms of diastolic depolarization
(DDR100); CaT duration (CaTD).
III. RESULTS
A. Updated Model
Table II compares AP and CaT features of the updated
model to the original model as well as to the experimental
data by Verkerk et al. [13]. AP features of the updated model
were closer to experimental values than those of the original
model except for APD90, AP overshoot, and the diastolic
depolarization rate during the first 100 ms (DDR100) which
is higher in the updated model leading to a more pronounced
biphasic diastolic deploarization. The CaT was of higher am-
plitude and shorter duration at 20% and 50% repolarization
but longer duration at 90% repolarization. The effect of If ,
INa, and IKs mutations (Fig. 1) was not markedly affected
by the changes to the model with a tendency towards bigger
effects for HCN4 mutations and smaller effects for SCN5A
mutations. The response to complete If block (cycle length
+25.9%) was in accordance with the available experimental
human data (+26% [13]).
B. Inter-Species Comparison
Fig. 2A shows how the different models respond to
changes of [Ca2+]o. While there is a consistent trend towards
longer cycle length, i.e. bradycardia, under hypocalcaemic
conditions, it is intriguingly stronger in the human sinus
node cell models (Fig. 2A, Fig. 3A). In contrast to the
original Fabbri et al. model, the extensions introduced in
this work attenuate the bradycardic effect of hypocalcaemia
indicating that variable intracellular ion concentrations can
counterbalance the effect of decreased [Ca2+]o to some
extent, although with a marked remaining effect of -40.7 bpm
when reducing [Ca2+]o from 1.8 to 0.9 mM. Pacemaking
brakes down for [Ca2+]o <1.2 mM in the original Fabbri
et al. model. The rabbit experimental data match the rabbit
model results (Fig. 3A). Decreasing [Ca2+]o causes higher
(absolute) maximum diastolic potential (MDP) consistently
across species with the exception of the Garny et al. rabbit
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Fig. 2. Effect of extracellular calcium concentration variation on action potential properties in sinus node cellular models of different species. Abbreviations:
diastolic depolarization rate over the first 100 ms of diastolic depolarization (DDR100), action potential duration at 90% repolarization (APD90).
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Fig. 3. Contribution of different temporal phases of the action potential to the dependence of pacemaking cycle length (A) on extracellular calcium
concentration changes (reference: 1.8 mM) in models of different species: first order approximation of diastolic depolarization based on early depolarization
(100 ms, B), action potential duration at 90% repolarization (C), diastolic depolarization not covered by first order approximation based on DDR100 (D).
model, which is insensitive (Fig. 2B). Decreasing [Ca2+]o
has little effect on DDR100 in the rabbit models whereas
spontaneous depolarization becomes slower in the human
models and, most pronounced, in the Kharche et al. mouse
model (Fig. 2C). APD90 is insensitive to [Ca2+]o changes in
the mouse model and showed an inverse relation in the Garny
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et al. rabbit model. In contrast, the Severi et al. rabbit model
and the human models exhibit a direct relation (Fig. 2D,
Fig. 3C).
We dissected the contribution of the different phases of the
pacemaking cycle to the cylce length dependence on [Ca2+]o
(Fig. 3A). The effect of early depolarization is quantified by
calculating a first order approximation of diastolic depolar-






tdia,late (Fig. 3D) on the other hand quantifies all changes
that are captured by neither changes in early depolarization
(tdia,100, Fig. 3B) nor by changes in APD90 (Fig. 3C).
While APD90 changes are responsible for only a minor
share of the overall effect, early depolarization becomes
slower under hypocalcaemic conditions in the Kharche et al.
mouse model and, most pronounced, in the human models.
While this effect is counterbalanced by tdia,late in the
mouse model, this is not the case for the human models.
Late depolarization becomes more important for [Ca2+]o
<1.5 mM, particularly for the updated human model.
IV. DISCUSSION
In this paper, we identified crucial inter-species differ-
ences in the response of cellular pacemaking in the si-
nus node to changes of extracellular ion concentrations,
as commonly occurring in CKD patients. The bradycardic
effect of hypocalcaemia was markedly more pronounced in
the human models compared to small animal models. The
pronounced effect is still present in the proposed updated
version of the Fabbri et al. model of human sinus node cells,
which exhibits homeostasis of intracellular ion concentra-
tions across time spans of minutes and thereby puts further
physiological constraints on the model parameters compared
to the original version without impairing reproduction of
experimental AP and CaT features. The similar behavior
of the Fabbri et al. model variants and the Severi et al.
model for APD90, (dV/dt)max, and overshoot could be due
to the fact that the latter served as basis to derive the former
model. When interpreting the effect in terms of absolute
[Ca2+]o, one should keep in mind the difference between
in vitro and in vivo reference concentrations (1.8–2.0 mM
vs. 1.0–1.3 mM) [14]. Future studies could investigate the
contribution of distinct currents and their complex interplay.
Moreover, the analysis of autonomic regulation as well as
pace-and-drive capability [15] adds other dimensions to the
problem of bradycardic SCD.
We conclude that the relevance of mouse and rabbit ex-
periments to investigate the effect of electrolyte-induced
changes of pacemaking appears questionable and human
experiments are needed to investigate the potential mech-
anism of hypocalcaemia-induced bradycardic SCD in CKD
patients.
TABLE III
INITIAL VALUES OF THE 33 ORDINARY DIFFERENTIAL EQUATIONS
CONSIDERED IN THE UPDATED HUMAN SINUS NODE CELL MODEL.
Parameter Initial value Parameter Initial value
Vm (mV) -46.19 [Ca]nsr (mM) 6.69e-01
[Ca]sub (mM) 8.60e-05 [Ca]i (mM) 1.27e-04
Nai (mM) 6.08 fTMM 5.92e-01
Ki (mM) 139.14 fCMi 2.78e-01
y 1.03e-02 fCMs 2.07e-01
m 3.78e-01 fTC 2.47e-02
h 5.20e-03 fTMC 3.30e-01
dL 1.40e-03 fCQ 1.88e-01
fL 9.95e-01 rKur 9.06e-03
fCa 7.82e-01 s 8.66e-01
dT 1.92e-01 q 4.74e-01
fT 3.75e-02 rto 1.25e-02
RCarel 9.00e-01 paS 3.45e-01
OCarel 1.75e-08 paF 8.34e-04
ICarel 1.88e-09 piy 7.37e-01
RICarel 9.68e-02 n 1.06e-01
[Ca]jsr (mM) 5.87e-01
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